Shock therapy for bladder control: new device aims to curb urgency
NCT ID NCT07300904
First seen Dec 29, 2025 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This study tests a device called Tensi+ that uses mild nerve stimulation to treat overactive bladder (OAB) symptoms like sudden urges to urinate and frequent bathroom trips. About 60 adults with OAB will use the device at home for 12 weeks. The goal is to see if it safely reduces urgency episodes and improves daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER (OAB) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai
Beverly Hills, California, 90211, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NYU Langone Health
New York, New York, 10017, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Toronto Western Hospital
Toronto, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.